Lobe Sciences Ltd.
LOBEF
$0.027
-$0.0005-1.82%
OTC PK
| 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | 11/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -582.00K | -2.07M | -313.20K | -443.20K | -416.00K |
| Total Depreciation and Amortization | -- | 0.00 | 20.70K | 21.00K | 20.70K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 223.60K | 1.85M | -95.00K | 47.90K | 50.70K |
| Change in Net Operating Assets | 181.70K | 201.50K | 151.20K | 351.00K | 275.20K |
| Cash from Operations | -176.70K | -10.40K | -236.30K | -23.30K | -69.40K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | 225.70K | 337.80K | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | 164.80K | 247.90K | -- | -- |
| Foreign Exchange rate Adjustments | 22.40K | -2.30K | 6.30K | -7.60K | 800.00 |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -154.30K | 152.10K | 18.00K | -30.90K | -68.60K |